251 related articles for article (PubMed ID: 8015217)
1. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
Shafer NP
Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
[No Abstract] [Full Text] [Related]
3. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
[TBL] [Abstract][Full Text] [Related]
4. [The use of tactivin for treating patients with IHD].
Klimov AN; Almazov VA; Nagornev VA; Denisenko AD; Pigarevskiĭ PV; Ogurtsov RP; Sergeeva EG; Sitnikova OD; Popov VG
Ter Arkh; 1995; 67(9):24-7. PubMed ID: 7495034
[TBL] [Abstract][Full Text] [Related]
5. [Use of the Gepon immunomodulator for ulcerative colitis treatment].
Malakhova NS; Pichugin AV; Khalif IL; Ataullakhanov RI
Eksp Klin Gastroenterol; 2005; (1):14-9, 106. PubMed ID: 15991847
[TBL] [Abstract][Full Text] [Related]
6. [The use of taktivin for modulating the functional activity of the neutrophilic granulocytes in patients with systemic lupus erythematosus].
Romanov VA; Borodin AG; Krylov VL
Ter Arkh; 1992; 64(5):65-9. PubMed ID: 1455381
[TBL] [Abstract][Full Text] [Related]
7. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
Balabolkin MI; Arion VIa; Petunina NA
Sov Med; 1987; (12):32-5. PubMed ID: 3502197
[No Abstract] [Full Text] [Related]
8. [Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
Shilov VA; Shirinskiĭ VS
Klin Med (Mosk); 1995; 73(4):88-90. PubMed ID: 7474838
[No Abstract] [Full Text] [Related]
9. [Effectiveness of immunostimulants in nonspecific ulcerative colitis].
Perederiĭ VG; Tkach SM; Bychkova NG; Blazhenko IL
Sov Med; 1990; (4):17-9. PubMed ID: 2374965
[TBL] [Abstract][Full Text] [Related]
10. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
Petunina NA; Balabolkin MI; Arion VIa
Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
[TBL] [Abstract][Full Text] [Related]
11. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
[No Abstract] [Full Text] [Related]
12. [Use of the immunomodulator thymalin in the treatment of nonspecific ulcerative colitis].
Shakhnazarov AA; Khavinson VKh; Morozov VG
Vrach Delo; 1984 Mar; (3):19-22. PubMed ID: 6547013
[No Abstract] [Full Text] [Related]
13. [T-activin in multimodal treatment of systemic lupus erythematosus in children].
Kartasheva VI; Tarasova LR; Zaĭrat'iants OV; Belokrinitskiĭ DV
Pediatriia; 1991; (3):47-52. PubMed ID: 2047179
[TBL] [Abstract][Full Text] [Related]
14. [Tactivin in combined treatment of patients with pulmonary tuberculosis associated with gastrointestinal diseases].
Zhukova EM
Probl Tuberk; 1995; (3):25-7. PubMed ID: 7617628
[TBL] [Abstract][Full Text] [Related]
15. [Use of taktivin in postoperative intensive therapy in oncology].
Gadalov VP; Arion VIa; Zhogoleva IB; Popova SR; Sviridova SP
Vestn Akad Med Nauk SSSR; 1988; (9):68-73. PubMed ID: 3201821
[No Abstract] [Full Text] [Related]
16. [Use of tactivin and imunofan for the treatment of patients with endometrial carcinoma].
Venediktova MG
Eksp Klin Farmakol; 2001; 64(5):46-9. PubMed ID: 11764501
[TBL] [Abstract][Full Text] [Related]
17. [The intraperitoneal administration of chemical preparations and taktivin in the combined treatment of stomach cancer].
Shchepotin IB; Chernyĭ VA; Grinevich IuA; Kamenets LIa; Osinskiĭ SP
Vrach Delo; 1988 Sep; (9):3-6. PubMed ID: 3212989
[No Abstract] [Full Text] [Related]
18. [Prevention and treatment of postoperative complications of hepatic echinococcosis].
Akhmedov RM; Ochilov UB; Mirkhodzhaev IA; Komilov TS; Makliev BIu
Med Parazitol (Mosk); 2003; (2):18-21. PubMed ID: 12886586
[TBL] [Abstract][Full Text] [Related]
19. [The use of taktivin in experimental apical periodontitis exacerbated by a secondary immunodeficiency state].
Zyrianov GV; Dmitrieva LA; Frolova TM; Belopol'skiĭ AA; Babaian SS
Stomatologiia (Mosk); 1993; 72(2):10-3. PubMed ID: 8048117
[TBL] [Abstract][Full Text] [Related]
20. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
